Management of Anticoagulant Therapy for Patients with Prosthetic Heart Valves or Atrial Fibrillation

References

• Cannegieter, S.C., Rosendaal, F.R. and Briet, E. (1994) "Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses", Circulation 89, 635–641.
   PubMed Web of Science ®Google Scholar
• Cannegieter, S.C., Rosendaal, F.R., Wintzen, A.R., et al. (1995) "Optimal oral anticoagulant therapy in patients with mechanical heart valves", N. Engl. J. Med. 333, 11–17.
   PubMed Web of Science ®Google Scholar
• Saour, J.N., Sieck, J.O., Mamo, L.A., et al. (1990) "Trial of different intensities of anticoagulation in patients with prosthetic heart valves", N. Engl. J. Med. 322, 428–432.
   PubMed Web of Science ®Google Scholar
• Acar, J., Jung, B., Boissel, J.P., et al. (1996) "AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves", Circulation 94, 2107–2112.
   PubMed Web of Science ®Google Scholar
• Vink, R., Kraaijenhagen, R.A., Hutten, B.A., van den Brink, R.B.A., de Mol, B.A., Buller, H.R. and Levi, M. (2003) "The optimal intensity of vitamin K antagonists in patients with mechanical heart valves; a meta-analysis", J. Am. Coll. Cardiol. 42, 2042–2048.
   PubMed Web of Science ®Google Scholar
• Turpie, A.G., Gent, M., Laupacis, A., et al. (1993) "A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement", N. Engl. J. Med. 329, 524–529.
   PubMed Web of Science ®Google Scholar
• Meschengieser, S.S., Fondevila, C.G., Frontroth, J., et al. (1997) "Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a random-ized trial in patients with mechanical prosthetic heart valves", J. Thorac. Cardiovasc. Surg. 113, 910–916.
   PubMed Web of Science ®Google Scholar
• Heras, M., Chesebro, J.H., Fuster, V, et al. (1995) "High risk of thromboemboli early after bioprosthetic cardiac valve replacement", J. Am. Coll. Cardiol. 25, 1111–1119.
   PubMed Web of Science ®Google Scholar
• Turpie, A.G., Gunstensen, J., Hirsh, J., et al. (1988) "Randomised comparison of two intensities of oral antic-oagulant therapy after tissue heart valve replacement", Lancet 1, 1242–1245.
   PubMed Web of Science ®Google Scholar
• Cohn, L.H., Collins, Jr., J.J., Rizzo, R.J., et al. (1998) "Twenty-year follow-up of the Hancock modified orifice porcine aortic valve", Ann. Thorac. Surg. 66, S30—S34.
   PubMed Web of Science ®Google Scholar
• Logeais, Y., Langanay, T., Corbineau, H., et al. (1998) "Aortic valve replacement in the elderly: bioprosthesis or mechanical valve?", Ann. Thorac. Surg. 66, S77—S81.
   PubMed Web of Science ®Google Scholar
• Goldsmith, I., Lip, G.Y., Mukundan, S., et al. (1998) "Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience", J. Heart Valve Dis. 7, 574–579.
   PubMed Web of Science ®Google Scholar
• Albers, G.W., Dalen, J.E., Laupacis, A., et al. (2001) "Anti-thrombotic therapy in atrial fibrillation", Chest 119, 194S–206S.
   PubMed Web of Science ®Google Scholar
• Masters, R.G., Semelhago, L.C., Pipe, A.L., et al. (1999) "Are older patients with mechanical heart valves at increased risk?", Ann. Thorac. Surg. 68, 2169–2172.
   PubMed Web of Science ®Google Scholar
• Sbarouni, E. and Oakley, CM. (1994) "Outcome of pregnancy in women with valve prostheses", Br. Heart J. 71, 196–201.
   PubMedGoogle Scholar
• Wong, V, Cheng, C.H. and Chan, K.C. (1993) "Fetal and neonatal outcome of exposure to anticoagulants during pregnancy", Am. J. Med. Genet. 45, 17–21.
   PubMed Web of Science ®Google Scholar
• Salazar, E., Izaguirre, R., Verdejo, J., et al. (1996) "Failure of adjusted doses of subcutaneous heparin to prevent thrombo-embolic phenomena in pregnant patients with mechanical cardiac valve prostheses", J. Am. Coll. Cardiol. 27, 1698–1703.
   PubMed Web of Science ®Google Scholar
• Lee, L.H., Liauw, P.C. and Ng, A.S. (1996) "Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement", Thromb. Haemost. 76, 628–630.
   PubMed Web of Science ®Google Scholar
• Ginsberg, J.S., Greer, I. and Hirsh, J. (2001) "Use of antithrombotic agents during pregnancy", Chest 119, 122S–131S.
   PubMed Web of Science ®Google Scholar
• Kearon, C. and Hirsh, J. (1997) "Management of anti-coagulation before and after elective surgery", N. Engl. J. Med. 336, 1506–1511.
   PubMed Web of Science ®Google Scholar
• Feinberg, W.M., Blackshear, J.L., Laupacis, A., et al. (1995) "Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications", Arch. Intern. Med. 155, 469–473.
   PubMed Web of Science ®Google Scholar
• Lamassa, M., Di Carlo, A.A., Pracucci, G., et al. (2001) "Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multi-national hospital-based registry (The European Community Stroke Project)", Stroke 32, 392–398.
   PubMed Web of Science ®Google Scholar
• Frost, L., Engholm, G., Johnsen, S., et al. (2000) "Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation", Am. J. Med. 108, 36–40.
   PubMed Web of Science ®Google Scholar
• Wolf, RA., Abbott, R.D. and Kannel, W.B. (1991) "Atrial fibrillation as an independent risk factor for stroke: the Framingham Study", Stroke 22, 983–988.
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators (1992) "Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk", Ann. Intern. Med. 116, 1–5.
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators (1992) "Predictors of thromboembolism in atrial fibrillation: Echocardiographic features of patients at risk", Ann. Intern. Med. 116, 6–12.
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators (1994) "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials", Arch. Intern. Med. 154, 1449–1457.
   PubMed Web of Science ®Google Scholar
• The Atrial Fibrillation Investigators (1998) "Echocardio-graphic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials", Arch. Intern. Med. 158, 1316–1320.
   PubMed Web of Science ®Google Scholar
• EAFT (European Atrial Fibrillation Trial) Study Group (1993) "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke", Lancet 342, 1255–1262.
   PubMed Web of Science ®Google Scholar
• The SPAF DI Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators(1998) "Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: stroke prevention in Atrial Fibrillation DI Study", J. Am. Med. Assoc. 279, 1273–1277.
   Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators (1996) "Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial", Lancet 348, 633–638.
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators (1991) "Stroke prevention in atrial fibrillation study. Final results", Circulation 84, 527–539.
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators (1994) "Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study", Lancet 343, 687–691.
   PubMed Web of Science ®Google Scholar
• "Transesophageal echocardiographic correlates of thrombo-embolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography". Ann. Intern. Med. 128 (1998) 639–647.
   PubMed Web of Science ®Google Scholar
• Hellemons, B.S., Langenberg, M., Lodder, J., et al. (1999) "Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin", Br. Med. J. 319, 958–964.
   PubMed Web of Science ®Google Scholar
• "Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ische-mia". N. Engl. J. Med. 333 (1995) 5–10.
   PubMed Web of Science ®Google Scholar
• Hylek, EM., Skates, S.J., Sheehan, M.A., et al. (1996) "An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation", N. Engl. J. Med. 335, 540–546.
   PubMed Web of Science ®Google Scholar
• Hylek, EM., Go, AS., Chang, Y., et al. (2003) "Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation", N. Engl. J. Med. 349, 1019–1026.
   PubMed Web of Science ®Google Scholar
• The Atrial Fibrillation Investigators (1997) "The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials", Arch. Intern. Med. 157, 1237–1240.
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators (1996) "Bleeding during antithrombotic therapy in patients with atrial fibrillation", Arch. Intern. Med. 156, 409–416.
   PubMed Web of Science ®Google Scholar
• Evans, A. and Kara, L. (2001) "Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?", Arch. Intern. Med. 161, 1443–1447.
   PubMed Web of Science ®Google Scholar
• Ezekowitz, M.D., Bridgers, S.L., James, K.E., et al. (1992) "Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investi-gators", N. Engl. J. Med. 327, 1406–1412.
   PubMed Web of Science ®Google Scholar
• Yusuf, S., Zhao, E, Mehta, SR., et al. (2001) "Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation", N. Engl. J. Med. 345, 494–502.
   PubMed Web of Science ®Google Scholar
• Petersen, R, Grind, M. and Adler, J. (2003) "Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study", J. Am. Coll. Cardiol. 41, 1445–1451.
   PubMed Web of Science ®Google Scholar
• SPORTIF ifi Investigators. (2003) "Stroke prevention using the oral direct thrombin inhibitor ximelagatran compared with dose-adjusted warfarin in patients with non-valvular atrial fibrillation", Lancet 362 (2003), 1691–1698.
   PubMedGoogle Scholar
• Berge, E., Abdelnoor, M., Nakstad, PH., et al. (2000) "Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial", Lancet 355, 1205–1210.
   PubMed Web of Science ®Google Scholar
• Stein, RD., Alpert, J.S., Bussey, HI., et al. (2001) "Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves", Chest 119, 220S–227S.
   PubMed Web of Science ®Google Scholar
• ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J. Am. Coll. Cardiol. 32 (1998) 1486–1588.
   PubMed Web of Science ®Google Scholar
• "Guidelines on oral anticoagulation: third edition". Br. J. Haematol. 101 (1998) 374–387.
   PubMedGoogle Scholar
• Gohlke-Barwolf, C., Acar, J., Oakley, C., et al. (1995) "Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology", Eur. Heart J. 16, 1320–1330.
   PubMed Web of Science ®Google Scholar
• van der Meer, F.J., Rosendaal, ER., Vandenbroucke, J.P., et al. (1996) "Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants", Thromb. Haemost. 76, 12–16.
   PubMed Web of Science ®Google Scholar
• Fihn, S.D., Callahan, CM., Martin, D.C., et al. (1996) "The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics", Ann. Intern. Med. 124, 970–979.
   PubMed Web of Science ®Google Scholar